X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2423) 2423
Publication (180) 180
Book Chapter (14) 14
Book Review (14) 14
Dissertation (6) 6
Conference Proceeding (5) 5
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1708) 1708
female (1316) 1316
oncology (1250) 1250
index medicus (1227) 1227
middle aged (1075) 1075
distant metastases (991) 991
aged (883) 883
male (873) 873
adult (833) 833
cancer (816) 816
prognosis (804) 804
distant metastasis (747) 747
metastasis (661) 661
surgery (600) 600
survival (535) 535
breast cancer (526) 526
retrospective studies (472) 472
neoplasm staging (452) 452
carcinoma (422) 422
aged, 80 and over (415) 415
radiotherapy (410) 410
chemotherapy (394) 394
care and treatment (377) 377
treatment outcome (336) 336
risk factors (335) 335
breast neoplasms - pathology (314) 314
analysis (301) 301
distant recurrence (301) 301
lymphatic metastasis (289) 289
disease-free survival (280) 280
recurrence (276) 276
medicine & public health (274) 274
follow-up studies (265) 265
tumors (258) 258
neoplasm metastasis (249) 249
radiology, nuclear medicine & medical imaging (246) 246
survival rate (240) 240
local recurrence (237) 237
survival analysis (235) 235
research (234) 234
health aspects (215) 215
therapy (215) 215
metastases (211) 211
neoplasm recurrence, local - pathology (206) 206
multivariate analysis (205) 205
patients (205) 205
diagnosis (200) 200
hematology, oncology and palliative medicine (200) 200
otorhinolaryngology (199) 199
radiation-therapy (197) 197
squamous-cell carcinoma (190) 190
combined modality therapy (186) 186
neoplasm recurrence, local (183) 183
head (173) 173
medical prognosis (173) 173
squamous cell carcinoma (172) 172
management (163) 163
risk (161) 161
adolescent (157) 157
follow-up (154) 154
expression (152) 152
immunohistochemistry (151) 151
prognostic-factors (149) 149
thyroid neoplasms - pathology (149) 149
patient outcomes (143) 143
breast neoplasms - mortality (141) 141
young adult (140) 140
carcinoma, squamous cell - pathology (139) 139
cancer patients (138) 138
head and neck neoplasms - pathology (138) 138
pathology (137) 137
cancer therapies (136) 136
radiation therapy (135) 135
breast neoplasms - drug therapy (134) 134
development and progression (134) 134
proportional hazards models (134) 134
breast neoplasms - genetics (133) 133
prognostic factors (132) 132
relapse (131) 131
gene expression (130) 130
thyroid cancer (130) 130
kaplan-meier estimate (129) 129
chemotherapy, adjuvant (126) 126
lung neoplasms - secondary (126) 126
estrogen-receptor (119) 119
nasopharyngeal carcinoma (115) 115
time factors (114) 114
carcinoma, squamous cell - secondary (113) 113
head and neck cancer (112) 112
medical research (111) 111
neoplasm invasiveness (111) 111
breast neoplasms - metabolism (110) 110
women (109) 109
breast neoplasms - surgery (108) 108
lymph nodes - pathology (108) 108
positron-emission-tomography (106) 106
breast neoplasms - therapy (105) 105
patterns (104) 104
tomography, x-ray computed (104) 104
genetic aspects (102) 102
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2331) 2331
German (45) 45
French (19) 19
Japanese (18) 18
Korean (11) 11
Spanish (7) 7
Russian (4) 4
Chinese (1) 1
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 08/2019, Volume 145, Issue 4, pp. 882 - 893
Many genomic assays that assess recurrence risk in early breast cancer (EBC) are prognostic, but they differ in risk group stratification, which can affect... 
risk score comparison | breast cancer | multigene tests | LATE DISTANT RECURRENCE | ONCOTYPE DX | RECEPTOR | MOLECULAR GRADE INDEX | PAM50 RISK | DECISION-MAKING | ONCOLOGY | INTRINSIC SUBTYPE | GENE-EXPRESSION | POSTMENOPAUSAL PATIENTS | CLINICAL-OUTCOMES | Genetic research | Genetic aspects | Breast cancer | Genes | Cancer | Breast | Head | Chemotherapy | Assaying | Health risks
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 01/2006, Volume 106, Issue 1, pp. 35 - 41
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 08/2016, Volume 13, Issue 8, pp. 470 - 472
The 21-gene recurrence score is a genetic assay developed to estimate the likelihood of distant recurrence in patients with oestrogen-receptor-positive,... 
WOMEN | RISK | THERAPY | ONCOLOGY | EXPRESSION | DISTANT RECURRENCE | Gene Expression Profiling | Prognosis | Receptors, Estrogen | Breast Neoplasms | Humans | Neoplasm Recurrence, Local
Journal Article
Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 1, pp. 131 - 137
BACKGROUND A 21‐gene expression assay (Oncotype DX recurrence score [RS]) that uses reverse transcriptase‐polymerase chain reaction is used clinically in... 
low risk | 21‐gene expression assay | recurrence score | age | distant metastasis | 21-gene expression assay | ASSAY | CANCER | CHEMOTHERAPY | WOMEN | IMPACT | DECISION-MAKING | ONCOLOGY | RECOMMENDATIONS | GENE-EXPRESSION | END-POINTS | ASSOCIATION | Lymph Nodes - pathology | Prognosis | Follow-Up Studies | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Receptors, Progesterone - genetics | Neoplasm Recurrence, Local - pathology | Young Adult | Neoplasm Metastasis - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Female | Receptors, Estrogen - genetics | Gene Expression Profiling - methods | Breast Neoplasms - drug therapy | Neoplasm Metastasis - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Neoplasm Metastasis - pathology | Tamoxifen - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Care and treatment | Diagnosis | Research | Breast diseases | Gene expression | Lymphatic system | RNA-directed DNA polymerase | Identification methods | Estrogens | Estrogen receptors | Data processing | Breast cancer | Metastasis | Tamoxifen | Cancer therapies | Patients | ErbB-2 protein | Lymph nodes | Metastases | Polymerase chain reaction | Breast carcinoma | Chemotherapy | Epidermal growth factor | Breast | Cancer | Lymph
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 11, pp. 2723 - 2729
Purpose: There is a paucity of biomarkers to predict failure in human papillomavirus-positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) following... 
SURVIVAL | HEAD | ONCOLOGY | MATTED NODES | DISTANT METASTASIS | RISK | SMOKING | SERUM ANTIBODIES | NECK-CANCER | EPIDEMIOLOGY | HPV | Carcinoma, Squamous Cell - blood | Oropharyngeal Neoplasms - immunology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Papillomavirus E7 Proteins - blood | Papillomavirus E7 Proteins - immunology | Male | Oropharyngeal Neoplasms - pathology | Antibodies, Viral - blood | Papillomavirus Infections - blood | Neoplasm Recurrence, Local - immunology | Papillomaviridae - immunology | Papillomavirus Infections - immunology | Adult | Female | Neoplasm Recurrence, Local - blood | Enzyme-Linked Immunosorbent Assay | Repressor Proteins - blood | Carcinoma, Squamous Cell - immunology | Biomarkers, Tumor - blood | Oncogene Proteins, Viral - blood | Repressor Proteins - immunology | Oropharyngeal Neoplasms - blood | Antibodies, Viral - immunology | Aged | Oncogene Proteins, Viral - immunology | Biomarkers, Tumor - immunology | Squamous cell carcinoma | Antibodies | Variance analysis | Patients | Serum levels | Dilution | Human papillomavirus | Immunogenicity | Glutathione transferase | Experimental design | Classification | Biomarkers | Enzyme-linked immunosorbent assay | Tumors | Glutathione | Smoking | Cancer | Recurrence | Oropharyngeal Squamous Cell Carcinoma | Predictive Biomarkers | HPV-Positive | E6 E7 Antibodies
Journal Article
Journal Article
Medicine, ISSN 0025-7974, 05/2018, Volume 97, Issue 20, p. e10754
Journal Article